The Effect of Vitamin D Supplementation on Cardiovascular Risk Factors

• Status: Completed
• Trial end date: 2017-09-01
• Target enrollment: 0
• Participant gender: All

Summary

Six-hundred subjects with vitamin D deficiency will be randomized to vitamin D 3000 IU per day versus placebo for 4 months, with effects on cardiovascular risk factors as main endpoint

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Tromso
• Treatments: Cholecalciferol; Ergocalciferols; Vitamin D; Vitamins

Criteria

Inclusion Criteria:

• participated in The 7th survey in The Tromsø study

• vitamin D deficiency

Exclusion Criteria:

• primary hyperparathyroidism

• granulomatous disease

• reduced kidney function

• systolic blood pressure > 174 mmHg

• diastolic blood pressure > 104 mmHg

• diabetes

• renal stones last 5 years

• use of solarium on regular basis

• planned holidays in tropical areas

• clinical depression

• clinical signs of vitamin D deficiency (muscle weakness)

• use of vitamin D supplements

• serious illness